Sacituzumab govitecan is the first ADC approved for upfront metastatic triple-negative breast cancer regardless of PD-L1 ...

Patients with MASLD often underreport alcohol use and even modest intake can block improvement. Drs VanWagner and Ajmera ...

Researchers find higher emotional eating scores during active pill use, though experts say the clinical significance remains ...

MASLD is a silent condition and labs may look normal. Drs VanWagner and Shubrook walk through who to screen, how to use FIB-4 ...

Among key uraemic toxins derived from tryptophan, higher indoxyl sulphate levels are independently associated with a greater ...

Researchers are examining how involuntary psychiatric admissions affect emergency clinicians, with findings expected to ...

With 104 matches across 16 host cities, the 2026 World Cup can turn recovery, hydration, and sleep into decisive performance ...

New imaging tools, exercise testing, and phenotype-based therapy are reshaping how clinicians diagnose and treat HFpEF.

As new clinical AI tools proliferate, students are growing worried about the burden of keeping up. Are medical schools doing ...

Mirvetuximab has come up short in the first randomized trial testing an antibody-drug conjugate plus standard carboplatin for ...

After 1 month of fremanezumab treatment, the risk for new-onset headache declined significantly across all weather patterns, ...

As AI continues to evolve, its integration into primary care is revolutionizing patient diagnosis, treatment, and management.